Merck scouts Thailand; Sun Pharma's Shanghvi reassures Ranbaxy execs; Pfizer recalls Viracept tablets;

> Merck KGaA is reportedly scouting Thailand for a site for a new manufacturing facility. Report

> Russia's anti-corruption law can pose a risk to drugmakers thinking about setting up manufacturing operations there. Blog post

> Pfizer ($PFE) is recalling 1,200 tablets of its HIV treatment Viracept because of labeling issues. Report

> Teva ($TEVA) is recalling some blister packs of desogestrel/ethinyl estradiol and ethinyl estradiol tablets that failed testing for impurities. Here and here

And Finally... Sun Pharmaceutical leader Dilip Shanghvi reportedly told Ranbaxy executives that his intention is not to "sack people" after his company completes the acquisition of Ranbaxy later this year. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.